Antimicrobial resistance and universal health coverage.
Antimicrobial resistance and universal health coverage.
复制标题
DOI：
10.1136/bmjgh-2017-000518
复制
发表时间：
2017
影响因子：
8.1
通讯作者：
Paulin S
中科院分区：
文献类型：
--
作者：
Bloom G;Merrett GB;Wilkinson A;Lin V;Paulin S
世卫组织于2015年启动了一项全球抗菌素耐药性行动计划(AMR)。七国集团、二十国集团和联合国大会的世界领导人已经宣布AMR是一场全球危机。世界各国领导人还将全民健康覆盖(UHC)作为可持续发展目标的关键目标。本文认为，这两项倡议都不太可能在孤立的情况下取得成功，政策目标应该是既提供适当的抗菌素治疗，又通过采取系统方法减少耐药性的出现和传播的风险。它侧重于人类感染的门诊治疗，并确定了实现这些政策目标所需的若干干预措施。然后，它展示了实现UHC卫生系统的关键属性的战略如何考虑到在任何国家将AMR作为UHC战略的一部分来解决的需要。报告最后列出了整合AMR和UHC倡议的建议优先行动清单。
The WHO launched a Global Action Plan on antimicrobial resistance (AMR) in 2015. World leaders in the G7, G20 and the UN General Assembly have declared AMR to be a global crisis. World leaders have also adopted universal health coverage (UHC) as a key target under the sustainable development goals. This paper argues that neither initiative is likely to succeed in isolation from the other and that the policy goals should be to both provide access to appropriate antimicrobial treatment and reduce the risk of the emergence and spread of resistance by taking a systems approach. It focuses on outpatient treatment of human infections and identifies a number of interventions that would be needed to achieve these policy goals. It then shows how a strategy for achieving key attributes of a health system for UHC can take into account the need to address AMR as part of a UHC strategy in any country. It concludes with a list of recommended priority actions for integrating initiatives on AMR and UHC.